2-(4-(2-(4-Methoxyphenyl)-3-methyl-1H-indol-5-yl)piperidin-1-yl)-N-methylethanamine

ID: ALA4645620

Chembl Id: CHEMBL4645620

PubChem CID: 58730809

Max Phase: Preclinical

Molecular Formula: C24H31N3O

Molecular Weight: 377.53

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CNCCN1CCC(c2ccc3[nH]c(-c4ccc(OC)cc4)c(C)c3c2)CC1

Standard InChI:  InChI=1S/C24H31N3O/c1-17-22-16-20(18-10-13-27(14-11-18)15-12-25-2)6-9-23(22)26-24(17)19-4-7-21(28-3)8-5-19/h4-9,16,18,25-26H,10-15H2,1-3H3

Standard InChI Key:  LXIQZKITRZKTAT-UHFFFAOYSA-N

Associated Targets(Human)

TLR9 Tclin Toll-like receptor 9 (943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR7 Tclin Toll-like receptor 7 (2626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR8 Tchem Toll-like receptor 8 (1853 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 377.53Molecular Weight (Monoisotopic): 377.2467AlogP: 4.55#Rotatable Bonds: 6
Polar Surface Area: 40.29Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.95CX LogP: 4.12CX LogD: 1.62
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.66Np Likeness Score: -0.51

References

1. Mussari CP, Dodd DS, Sreekantha RK, Pasunoori L, Wan H, Posy SL, Critton D, Ruepp S, Subramanian M, Watson A, Davies P, Schieven GL, Salter-Cid LM, Srivastava R, Tagore DM, Dudhgaonkar S, Poss MA, Carter PH, Dyckman AJ..  (2020)  Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9).,  11  (9): [PMID:32944143] [10.1021/acsmedchemlett.0c00264]
2. Sreekantha RK, Mussari CP, Dodd DS, Pasunoori L, Hegde S, Posy SL, Critton D, Ruepp S, Subramanian M, Salter-Cid LM, Tagore DM, Sarodaya S, Dudhgaonkar S, Poss MA, Schieven GL, Carter PH, Macor JE, Dyckman AJ..  (2022)  Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8).,  13  (5.0): [PMID:35586440] [10.1021/acsmedchemlett.2c00049]

Source